Earlier Diagnosis of VHD: Imaging and AI with Juan Granada and Pierre Elias
Juan Granada and Pierre Elias discuss how AI is an essential tool for improving screening access and increasing early diagnosis of valvular heart disease.
2 Touko 202519min
Earlier Diagnosis of VHD: Biomarkers and Genetics with Juan Granada and Brian Lindman
Juan Granada and Brian Lindman share insights on tools and data that can be used to achieve earlier diagnosis and intervention in valvular heart disease.
18 Huhti 202515min
Technology's Role in Treating Severe AS with Sammy Elmariah and David Playford
Sammy Elmariah and David Playford discuss the ways technology and AI can be used to assist in better treatment and diagnosis of severe aortic stenosis.
4 Huhti 202514min
Women’s Heart Health Series: How to Make a Difference Roundtable
Martha Gulati and Kathyn Berlacher talk about tangible ways to improve women's cardiovascular care, including nontraditional, patient-centered solutions.
6 Maalis 202517min
Women’s Heart Health Series: Undertreatment – How Does Change Happen?
Clyde Yancy, Suzanne Baron, and Bruce Rutkin discuss ways to address the undertreatment of CVD in women at the patient, provider, structural, and societal levels.
27 Helmi 202518min
Women’s Heart Health Series: Underdiagnosis of Heart Disease in Women – What Are the Barriers?
Clyde Yancy talks to Sharonne Hayes and Robert Harrington about the barriers that have historically hindered diagnosing heart disease in women, including sex differences in disease presentation and ou...
27 Helmi 202518min
Women's Heart Health Series: Achieving Health Equity
Clyde Yancy talks to Priya Freaney and Nisha Parikh about the landscape of cardiovascular care for women and how it can be improved, both for patients and women training to be cardiologists.
20 Helmi 202516min
Women's Heart Health Series: Underrepresentation of Women in Cardiology – Is There a Solution?
Clyde Yancy, Roxana Mehran, and Howard Herrmann discuss strategies for increasing clinical trial enrollment among women, including targeting disease phenotypes and sex-specific trials.
20 Helmi 202516min
